Home » Topics » Regulatory » Patents

Patents
RSS

Merck Patent and Cancer Research Technology develop CDK8/19 inhibitors

Feb. 1, 2016

Pfizer reports muscarinic M1 PAMs

Feb. 1, 2016

BeiGene reports inhibitors of EGFR T790M mutant

Feb. 1, 2016

Biogen divulges IRAK-4 inhibitors

Jan. 29, 2016

Novogen patent reports tropomyosin alpha-3 chain inhibitors

Jan. 29, 2016

HEC Pharm presents FLT3 inhibitors

Jan. 29, 2016

Gruenenthal discloses phosphodiesterase 4B inhibitors

Jan. 29, 2016

University of Texas System patents mitochondrial GLS inhibitors

Jan. 28, 2016

Alpharmagen discloses nicotinic acetylcholine alpha7 modulators

Jan. 28, 2016

University of Texas System patents mitochondrial GLS1 inhibitors

Jan. 27, 2016

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...